Document is current
Any future updates will be listed below
-
Authors
Adán-Castro, Elva
Zamora, Magdalena
Granados-Carrasco, Daniela
Siqueiros-Márquez, Lourdes
García-Rodrigo, Jose F.
Macias, Fernando
Bertsch, Thomas
Triebel, Jakob
Arnold, Edith
Martínez de la Escalera, Gonzalo
Robles, Juan Pablo
Clapp, Carmen
-
Funding
Funding for this research was provided by:
Secretaría de Educación, Ciencia, Tecnología e Innovación de la Ciudad de México (SECTEI/061/2023, SECTEI/061/2023, SECTEI/061/2023, SECTEI/061/2023, SECTEI/061/2023, SECTEI/061/2023, SECTEI/061/2023, SECTEI/061/2023, SECTEI/061/2023, SECTEI/061/2023, SECTEI/061/2023, SECTEI/061/2023)
- License Information
-
More Information
Article History
Received: 18 September 2024
Accepted: 16 July 2025
First Online: 23 July 2025
Declarations
:
: JPR, MZ, TB, JT, GME, and CC are inventors of a submitted patent application (WO/2021/098996), which is owned by the Universidad Nacional Autónoma de México (UNAM) and JT. JPR is the CEO and founder of VIAN Therapeutics Inc. MZ and CC are consultants for VIAN Therapeutics. Inc.
